Culture Process TRIZ Cases

Non-adherent suspension prevents renal function deterioration during extended culture periods.

Cultures pluripotent cells on untreated substrates using a defined medium with bFGF, eliminating feeder cell complexity.

A nanofibrillar cellulose hydrogel matrix supports eukaryotic cells at 1-25°C without cryoprotectants.

Segmented induction media compositions drive human pluripotent stem cell maturation into functional podocytes within twelve days.

A serum-free medium supports mesenchymal stem cell growth using fibroblast growth factor, transforming growth factor beta, and lipoproteins.

Electrical stimulation induces fibroblast transdifferentiation into chondrocytes within micromass cultures.

Exposing cells to 6-35 GHz electromagnetic energy achieves transfection efficiency while maintaining viability across prokaryotic and eukaryotic populations.

Planar vascularized brain cancer organoids replicate the human tissue microenvironment to resolve accuracy-versus-efficiency trade-offs in drug discovery.

UM171 expands CD34+ hematopoietic progenitors while resolving lineage commitment specificity issues.

A tankyrase inhibitor-regulated naive human induced pluripotent stem cell bank generates clinical-grade therapeutic progenitors.

Chemically defined serum-free media expand adherent stromal cells while eliminating fetal bovine serum ethical concerns and costs.

Thermoreversible polymer hydrogels form a three-dimensional matrix to support stem cell growth and differentiation.

MAIT cells suppress donor T cell expansion to delay graft-versus-host disease onset without broad immunosuppression.

Filtrate from young adult stem cells restores functional quality in aged cells, reducing breast cancer presence in bone marrow models.

Purifying native Wharton's jelly stem cells via mechanical mincing and enzymatic digestion to yield noncultured therapeutic agents.

Reducing surface fucosylation via fucose analogs improves T cell targeting specificity while minimizing off-target effects on healthy tissues.

Laminated epithelial and stromal cell sheets heal intrauterine adhesions by preventing re-adhesion through preliminary action.

Regenerative cell therapy administered to brain-dead donors expands the viable donor pool by repairing marginal organs through postmortem tissue regeneration.

Derivatization and encapsulation protect labile compounds within cell culture media, extending shelf life at ambient temperatures.

Recombinant laminin-511 replaces undefined feeder cells to eliminate pathogen transmission risks while maintaining pluripotency.

Regenerative fibroblast cells secrete growth factors to stimulate endothelial proliferation and new blood vessel formation in erectile tissue.

Plasma-induced apoptotic microvesicles stimulate dendritic cells to isolate antigen-specific T cells, reducing tissue damage in systemic cancer treatment.

UV crosslinking strengthens the GelMA alginate pectin hydrogel scaffold, resolving breakage risks and eliminating expensive differentiation media costs.

PKC activators and HDAC inhibitors increase viral vector titre while maintaining cell viability during GMP manufacturing.

Educated CD14+ cells generate anti-inflammatory macrophages via TLR4 agonist exposure, addressing toxicity in acute radiation syndrome treatments.

Desulphated glycosaminoglycan culture medium expands haematopoietic progenitor cells while maintaining potency.

Platelet lysate in non-adhesion culture boosts dendritic cell yield and cytotoxicity, resolving low productivity and weak function trade-offs.

Removing glucose and low molecular weight molecules from serum via dialysis stabilizes beating frequency and prevents non-cardiomyocyte outgrowth.

Heat treatment at 56°C decomposes proteins into peptides without degrading the exosome membrane, enabling long-term storage and enhanced antigen presentation.

A serum-free priming medium induces stem cells to adopt an anti-inflammatory phenotype through targeted cytokine signaling.

Differentiate human pluripotent stem cells into high-purity epicardial cells using chemically defined, albumin-free conditions and Gsk3 inhibitors.

Differentiating human stem cells into peripheral sensory neurons using defined culture media and specific growth factors.

Culturing somatic cells with MEK inhibitors and cAMP inducers to produce cardiomyocytes without gene transfer.

Enzymatic digestion releases cardiac progenitor cells from tissue samples for subsequent immunomagnetic selection.

A method differentiating mammalian pluripotent stem cells into neural plate border stem cells using specific signaling pathway modulators.

ABM-M culture medium combines DMEM high glucose, RPMI-1640, and Ham's F-12 to boost mesenchymal stem cell growth while maintaining undifferentiated states.

Hypoxic culture conditions drive pluripotent stem cell differentiation into cardiomyocytes without exogenous growth factors.

Heat treatment standardizes poloxamer properties, resolving lot variability that reduces cell viability and protein production.

Matrigel scaffold enables long-term human tooth epithelial stem cell expansion while maintaining phenotype stability.

A chemically defined serum-free medium differentiates adipogenic progenitor cells into mature adipocytes using specific growth factors and hormones.

Segmentation and extraction of CXCR4-positive progenitors induce dendritically branched collecting ducts in kidney organoids.

Culturing chondrocytes on a temperature-responsive polymer membrane stops before type II collagen accumulation to prevent immune rejection.

A growth medium containing fetal bovine serum and fibroblast growth factor supports mesenchymal stem cell proliferation.

Contacting nephron progenitor cells with FGFR, BMP, and WNT inhibitors generates human podocytes.

Stem cell-derived induced dermal papillae cells overcome culture-induced loss of hair-inducing ability to treat alopecia.

Cortical bone-derived stem cells differentiate into mature cardiac muscle cells.

Adding purified growth arrest-specific 6 to a basal medium supports stable stem cell proliferation while eliminating animal-derived contamination risks.

Defined serum-free media with BMP4 and VEGF induce dendritic cell differentiation from pluripotent stem cells, eliminating lot-to-lot variation.